MBAI

Check-Cap Ltd. - Ordinary Share (MBAI)

About Check-Cap Ltd. - Ordinary Share (MBAI)

Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.

Details

Daily high

$8.40

Daily low

$7.92

Price at open

$8.30

52 Week High

$27.44

52 Week Low

$4.20

Market cap

10.8M

Dividend yield

Volume

13,846

Avg. volume

16,621

P/E ratio

10.87

Check-Cap Ltd. - Ordinary Share News